Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.263
+0.004 (1.55%)
At close: Nov 4, 2024, 4:00 PM
0.256
-0.007 (-2.62%)
Pre-market: Nov 5, 2024, 5:32 AM EST
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $17.21 million as of November 5, 2024. Its market cap has decreased by -90.10% in one year.
Market Cap
17.21M
Enterprise Value
-13.54M
1-Year Change
-90.10%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $229.70M to $17.21M, a decrease of -92.51%. That is a compound annual growth rate of -43.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 17.00M | -93.83% |
| Dec 29, 2023 | 275.40M | 175.68% |
| Dec 30, 2022 | 99.90M | 76.19% |
| Dec 31, 2021 | 56.70M | -61.53% |
| Dec 31, 2020 | 147.40M | -35.83% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 17.60M |
| Innovative Eyewear | 17.57M |
| Kairos Pharma | 17.21M |
| Synlogic | 17.08M |
| NanoViricides | 16.78M |
| AIM ImmunoTech | 16.53M |
| Kazia Therapeutics | 16.45M |
| GeoVax Labs | 16.37M |